Tag: generic drug litigation
Litigation in Generic Markets: How Patent Disputes Delay Affordable Medicines
Patent disputes in the generic drug market delay affordable medicines, costing billions annually. Learn how the Hatch-Waxman Act, Orange Book listings, and serial litigation block competition-and what’s being done to fix it.
read more